Background/Aims: Some minimal changes (MCs) are believed to have a certain relationship with gastroesophageal reflux (GERD). Nonetheless, the individual meaning of MC is still unclear. Our aim was to compare the overall and individual prevalence of MC between patients with non-erosive reflux disease (NERD) and healthy controls (HC). Methods: Twelve endoscopic findings in the esophagogastric junction were prospectively compared between NERD (n = 64) and control (n = 104). Results: Overall frequency of MC (≥1 out of 12 criteria) was higher in the NERD group (71.9%) than in the HC group (45.2%). In individual analysis, white mucosal turbidity, irregular Z-line, horizontal erosions, and mucosal protrusion of cardia were significantly more common in the NERD group compared to controls. Among them, only white mucosal turbidity was independently associated with the NERD group (OR 3.97, 95% CI 1.72–9.13). Individuals with male gender, reflux symptoms, higher height, current smoking, ethanol intake and hiatal hernia were more likely to have white mucosal turbidity compared to the group without white turbidity. Conclusions: MC could be a useful marker to support clinical diagnosis of GERD. White mucosal turbidity in particular might be a GERD-specific sign related to acid-induced mucosal damage.

1.
Vakil N, van Zantenl SV, Kahrilas P, Dent J, Jones R, Global Consensus Group: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–1920.
[PubMed]
2.
Hoshihara Y: Endoscopic findings of GERD (in Japanese). Nippon Rinsho 2004;62:1459–1464.
[PubMed]
3.
Hongo M: Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol 2006;41:95–99.
[PubMed]
4.
Lee JH, Kim N, Chung IK, Jo YJ, Seo GS, Kim SW, Im EH, Kim HR, Park SH, Lee SY, Cha HM, Lee KS, Hyun DH, Kim HY, Kim SM, Shin JE, Park SH, Chung HC, Chung IS: H. pylori and GERD Study Group of Korean College of Helicobacter and Upper Gastrointestinal Research. Clinical significance of minimal change lesions of the esophagus in a healthy Korean population: a nationwide multi-center prospective study. J Gastroenterol Hepatol 2008;23:1153–1157.
5.
Miwa H, Yokoyama T, Hori K, Sakagami T, Oshima T, Tomita T, Fujiwara Y, Saita H, Itou T, Ogawa H, Nakamura Y, Kishi K, Murayama Y, Hayashi E, Kobayashi K, Tano N, Matsushita K, Kawamoto H, Sawada Y, Ohkawa A, Arai E, Nagao K, Hamamoto N, Sugiyasu Y, Sugimoto K, Hara H, Tanimura M, Honda Y, Isozaki K, Noda S, Kubota S, Himeno S: Interobserver agreement in endoscopic evaluation of reflux esophagitis using a modified Los Angeles Classification incorporating grades N and M: a validation study in a cohort of Japanese endoscopists. Dis Esophagus 2008;21:355–363.
[PubMed]
6.
Amano Y, Ishimura N, Furuta K, Okita K, Masaharu M, Azumi T, Ose T, Koshino K, Ishihara S, Adachi K, Kinoshita Y: Interobserver agreement on classifying endoscopic diagnoses of nonerosive esophagitis. Endoscopy 2006;38:1032–1035.
7.
Edebo A, Tam W, Bruno M, Van Berkel AM, Jönson C, Schoeman M, Tytgat G, Dent J, Lundell L: Magnification endoscopy for diagnosis of nonerosive reflux disease: a proposal of diagnostic criteria and critical analysis of observer variability. Endoscopy 2007;39:195–201.
[PubMed]
8.
Nakamura T, Shirakawa K, Masuyama H, Sugaya H, Hiraishi H, Terano A: Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis. Aliment Pharmacol Ther 2005;21(suppl 2):19–26.
[PubMed]
9.
Kiesslich R, Kanzler S, Vieth M, Moehler M, Neidig J, Thanka Nadar BJ, Schilling D, Burg J, Nafe B, Neurath MF, Galle PR: Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis 2004;22:221–227.
[PubMed]
10.
Fass R, Fennerty MB, Vakil N: Nonerosive reflux disease – current concepts and dilemmas. Am J Gastroenterol 2001;96:303–314.
[PubMed]
11.
Wang C, Hunt RH: Precise role of acid in non-erosive reflux disease. Digestion 2008;78(suppl 1):31–41.
12.
Joh T, Miwa H, Higuchi K, Shimatani T, Manabe N, Adachi K, Wada T, Sasaki M, Fujiwara Y, Hongo M, Chiba T, Kinoshita Y, ARS Research Group: Validity of endoscopic classification of nonerosive reflux disease. J Gastroenterol 2007;42:444–449.
[PubMed]
13.
Kim JH, Park H, Lee YC, MIGHT Study Group: Is minimal change esophagitis really part of the spectrum of endoscopic findings of gastroesophageal reflux disease? A prospective, multicenter study. Endoscopy 2011;43:190–195.
14.
Takubo K, Honma N, Aryal G, Sawabe M, Arai T, Tanaka Y, Mafune K, Iwakiri K: Is there a set of histologic changes that are invariably reflux associated? Arch Pathol Lab Med 2005;129:159–163.
[PubMed]
15.
Gaddam S, Wani S, Ahmed H, Maddur P, Hall SB, Gupta N, Puli SR, Higbee A, Rastogi A, Bansal A, Sharma P: The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis. Aliment Pharmacol Ther 2010;32:1266–1274.
16.
Fass R, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE, Fennerty MB: Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999;159:2161–2168.
[PubMed]
17.
Gasiorowska A, Fass R: The proton pump inhibitor test in GERD: does it still have a role? J Clin Gastroenterol 2008;42:867–874.
[PubMed]
You do not currently have access to this content.